PRNewsWire
07 Nov 2026, 00:38 UTC · 1h ago
Tenax Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - TENX
Impact · against what's priced in
Tenax Therapeutics faces potential financial and operational headwinds due to a securities class action lawsuit alleging misrepresentations of its TNX-103 drug. Chemours and Millrose Properties are also mentioned as subjects of separate lawsuits, introducing potential legal liabilities for those firms.
- TENX−0.40
No priced-in read yet





